{"Literature Review": "The study of immunity to infection has been a cornerstone of biomedical research, with significant contributions from both human and mouse models. However, the discrepancies between findings in these two systems have often led to skepticism and neglect from researchers on either side. This literature review aims to reconcile the differences by examining the genetic underpinnies of immune responses in both humans and mice, highlighting the importance of a genetic perspective in understanding these discrepancies. Mouse models have been instrumental in elucidating the molecular mechanisms of the immune system. Through the use of knockout and transgenic mice, researchers have been able to dissect the roles of specific genes and pathways in immune function. For instance, studies on Toll-like receptors (TLRs) in mice have provided fundamental insights into the recognition of pathogen-associated molecular patterns (PAMPs) and the subsequent activation of innate immune responses. However, the controlled environment and experimental nature of mouse studies can sometimes lead to results that do not fully translate to the human context. On the other hand, human studies, particularly those involving patients with inborn errors of immunity, offer a unique window into the natural history of immune disorders. These studies have identified numerous genetic mutations that result in specific immunodeficiencies, providing valuable information about the functional importance of various immune components. For example, mutations in the gene encoding the interleukin-2 receptor gamma chain (IL2RG) have been shown to cause severe combined immunodeficiency (SCID), highlighting the critical role of this protein in T-cell and NK-cell development. Despite the wealth of information provided by both mouse and human studies, the infectious phenotypes observed in patients with inborn errors of immunity often differ from those seen in corresponding mutant mice. This discrepancy can be attributed to several factors, including the complexity of the human immune system, the presence of compensatory mechanisms, and the influence of environmental factors. For instance, while a particular mutation may lead to a severe phenotype in mice, the same mutation in humans might result in a milder or even asymptomatic condition due to the redundancy and plasticity of the human immune system. To address these discrepancies, it is essential to revisit and reinterpret the findings of both mouse and human studies from a genetic perspective. Genetic analysis can help identify the specific genetic variants responsible for the observed phenotypes and provide insights into the underlying mechanisms. For example, the use of next-generation sequencing (NGS) technologies has revolutionized the identification of rare genetic variants associated with immunodeficiencies in humans. Similarly, the application of CRISPR-Cas9 technology in mice has enabled the precise editing of the genome, allowing for more accurate modeling of human genetic disorders. Moreover, the integration of data from both human and mouse studies can provide a more comprehensive understanding of the immune system. For instance, the identification of a genetic mutation in humans can guide the creation of a corresponding mouse model, which can then be used to study the functional consequences of the mutation in a controlled setting. Conversely, findings from mouse studies can inform the design of clinical studies in humans, leading to more targeted and effective therapeutic interventions. In conclusion, while there are inherent differences between mouse and human immunology, a genetic perspective can bridge these gaps and provide a more unified understanding of the immune system. By combining the strengths of both approaches, researchers can gain deeper insights into the mechanisms of immunity to infection and develop more effective strategies for preventing and treating immunological disorders.", "References": [{"title": "Altering genes in animals by gene targeting", "authors": "B. H. Koller, O. Smithies", "journal": "Annual Review of Immunology", "year": "1992", "volumes": "10", "first page": "739", "last page": "794", "DOI": "10.1146/annurev.immunol.10.1.739"}, {"title": "Pathogen recognition and innate immunity", "authors": "S. Akira, S. Uematsu, O. Takeuchi", "journal": "Cell", "year": "2006", "volumes": "124", "first page": "783", "last page": "801", "DOI": "10.1016/j.cell.2006.02.015"}, {"title": "Genomic responses in mouse models poorly mimic human inflammatory diseases", "authors": "J. Seok, H. S. Warren, A. G. Cuenca, M. N. Mindrinos, H. V. Baker, W. Xu, R. W. Davis", "journal": "Proceedings of the National Academy of Sciences", "year": "2013", "volumes": "110", "first page": "3507", "last page": "3512", "DOI": "10.1073/pnas.1222878110"}, {"title": "Primary immunodeficiencies", "authors": "L. D. Notarangelo", "journal": "Journal of Allergy and Clinical Immunology", "year": "2010", "volumes": "125", "first page": "S182", "last page": "S194", "DOI": "10.1016/j.jaci.2009.07.053"}, {"title": "Molecular defects in primary immunodeficiencies", "authors": "J. M. Puck", "journal": "Journal of Allergy and Clinical Immunology", "year": "2007", "volumes": "119", "first page": "1273", "last page": "1280", "DOI": "10.1016/j.jaci.2007.03.002"}, {"title": "Human genetics of infectious diseases: a unified theory", "authors": "J. L. Casanova, L. Abel", "journal": "EMBO Reports", "year": "2007", "volumes": "8", "first page": "109", "last page": "113", "DOI": "10.1038/sj.embor.7400911"}, {"title": "Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency", "authors": "C. Picard, W. Al-Herz, A. A. Bousfiha, J. L. Casanova, T. Chatila, M. E. Conley, M. L. Tang", "journal": "Journal of Clinical Immunology", "year": "2015", "volumes": "35", "first page": "6", "last page": "16", "DOI": "10.1007/s10875-014-0122-6"}, {"title": "Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency", "authors": "B. Boisson, E. Laplantine, C. Prando, S. Giliani, B. Israel, Z. Xu, J. L. Casanova", "journal": "Nature Immunology", "year": "2013", "volumes": "14", "first page": "1008", "last page": "1016", "DOI": "10.1038/ni.2686"}, {"title": "CRISPR/Cas9 in genome editing and beyond", "authors": "H. Wang, M. La Russa, L. S. Qi", "journal": "Annual Review of Biochemistry", "year": "2016", "volumes": "85", "first page": "227", "last page": "264", "DOI": "10.1146/annurev-biochem-060815-014607"}, {"title": "Gene targeting in the mouse: a review", "authors": "Y. Zhang, M. Conti", "journal": "Molecular Reproduction and Development", "year": "2014", "volumes": "81", "first page": "836", "last page": "846", "DOI": "10.1002/mrd.22400"}]}